Edition:
United States

People: Brainstorm Cell Therapeutics Inc (BCLI.OQ)

BCLI.OQ on NASDAQ Stock Exchange Capital Market

3.15USD
16 Nov 2018
Change (% chg)

$0.01 (+0.32%)
Prev Close
$3.14
Open
$3.15
Day's High
$3.21
Day's Low
$3.14
Volume
2,594
Avg. Vol
9,982
52-wk High
$5.34
52-wk Low
$2.88

Lebovits, Chaim 

Mr. Chaim Lebovits is President, Chief Executive Officer of the Company. He joined the Company in July 2007 as President. On August 1, 2013, the Company appointed Mr. Lebovits as its Principal Executive Officer, and to assume the duties and responsibilities of the Chief Executive Officer on an interim basis until June 2014. On September 22, 2015, the Company appointed Chaim Lebovits as its Chief Executive Officer. Mr. Lebovits controls ACC Holdings International, and its subsidiaries ACC Resources, specializing in the mining, oil and energy industries, and ACC BioTech, which is focused on biotechnology. He has been at the forefront of mining and natural resource management in the African region for over a decade and has spent years leading the exploration and development of resources in West Africa and Israel and served as a member of the board of directors of several companies in the industry. Mr. Lebovits has also held senior positions for the worldwide Chabad Lubavitch organization, the largest Jewish organization in the world today.

Basic Compensation

Total Annual Compensation, USD 423,750
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 130,000
Fiscal Year Total, USD 553,750

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --